Cargando…
美法仑联合大剂量地塞米松一线治疗原发性轻链型淀粉样变的疗效分析
OBJECTIVE: To evaluate the response of oral melphalan plus high-dose dexamethasone (MDex) for patients with primary light chain amyloidosis (pAL). METHODS: Clinical data, hematological and organ responses, and survival of 76 patients with pAL who had received MDex from January 2009 to July 2017 were...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342839/ https://www.ncbi.nlm.nih.gov/pubmed/30180464 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.08.006 |
Ejemplares similares
-
原发性轻链型淀粉样变的诊断和治疗中国专家共识(2016年版)
Publicado: (2016) -
单克隆IgM相关轻链型淀粉样变的临床特征和预后分析
Publicado: (2017) -
达雷妥尤单抗治疗晚期轻链型淀粉样变的疗效和安全性
Publicado: (2022) -
自体外周血造血干细胞移植与硼替佐米联合地塞米松治疗原发性轻链型淀粉样变性的疗效和安全性比较
Publicado: (2016) -
我如何治疗系统性轻链型淀粉样变性
Publicado: (2017)